Christian Delles

ORCID: 0000-0003-2238-2612
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Blood Pressure and Hypertension Studies
  • Cardiovascular Health and Disease Prevention
  • Pregnancy and preeclampsia studies
  • Hormonal Regulation and Hypertension
  • Birth, Development, and Health
  • Sodium Intake and Health
  • Advanced Proteomics Techniques and Applications
  • Chronic Kidney Disease and Diabetes
  • Cardiac Imaging and Diagnostics
  • Renin-Angiotensin System Studies
  • Metabolomics and Mass Spectrometry Studies
  • Nitric Oxide and Endothelin Effects
  • Heart Rate Variability and Autonomic Control
  • Cardiovascular Function and Risk Factors
  • Nutritional Studies and Diet
  • Cardiovascular Disease and Adiposity
  • Hemodynamic Monitoring and Therapy
  • Renal and Vascular Pathologies
  • Genetic Associations and Epidemiology
  • Lipoproteins and Cardiovascular Health
  • Cerebrovascular and Carotid Artery Diseases
  • MicroRNA in disease regulation
  • Heart Failure Treatment and Management
  • Diabetes Treatment and Management
  • Thermoregulation and physiological responses

University of Glasgow
2016-2025

Queen Elizabeth University Hospital
2016-2025

University of Naples Federico II
2024

Charité - Universitätsmedizin Berlin
2000-2024

Theranostics (New Zealand)
2024

Glasgow Centre for Population Health
2024

NHS Greater Glasgow and Clyde
2019-2024

British Heart Foundation
2007-2022

University of Copenhagen
2022

Semmelweis University
2022

Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici (Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luís Bronze (Portugal), John Chalmers (Australia), Tine De Backer (Belgium), Alejandro de la Sierra (Spain), Kyriakos Dimitriadis Dorota Drozdz (Poland), Béatrice Duly-Bouhanick (France), Brent M. Egan (USA), Serap Erdine Claudio Ferri (Italy), Slavomira Filipova (Slovak Republic), Anthony Heagerty (UK), Michael Hecht Olsen (Denmark), Dagmara Hering...

10.1097/hjh.0000000000003480 article EN Journal of Hypertension 2023-06-24

Because of its availability, ease collection, and correlation with physiology pathology, urine is an attractive source for clinical proteomics/peptidomics. However, the lack comparable data sets from large cohorts has greatly hindered development proteomics. Here, we report establishment a reproducible, high resolution method peptidome analysis naturally occurring human urinary peptides proteins, ranging 800 to 17,000 Da, using samples 3,600 individuals analyzed by capillary electrophoresis...

10.1074/mcp.m110.001917 article EN cc-by Molecular & Cellular Proteomics 2010-07-09

Hypertension is a heritable and major contributor to the global burden of disease. The sum rare common genetic variants robustly identified so far explain only 1%–2% population variation in BP hypertension. This suggests existence more undiscovered variants. We conducted genome-wide association study 1,621 hypertensive cases 1,699 controls follow-up validation analyses 19,845 16,541 using an extreme case-control design. locus on chromosome 16 5′ region Uromodulin (UMOD; rs13333226, combined...

10.1371/journal.pgen.1001177 article EN cc-by PLoS Genetics 2010-10-28
John W. McEvoy Cian P. McCarthy Rosa María Bruno Sofie Brouwers Michelle Canavan and 95 more Claudio Ceconi Ruxandra Christodorescu Stella S. Daskalopoulou Charles J. Ferro Eva Gerdts Henner Hanssen Julie Harris Lucas Lauder Richard J. McManus Gerard J. Molloy Kazem Rahimi Vera Regitz‐Zagrosek Gian Paolo Rossi Else Charlotte Sandset Bart Scheenaerts Jan A. Staessen Izabella Uchmanowicz Maurizio Volterrani Rhian M. Touyz Ana Abreu Michael Hecht Olsen Marco Ambrosetti Emmanuel Androulakis Lia E. Bang Jesper Nørgaard Bech Michael A. Borger Pierre Boutouyrie Luís Bronze Sergio Buccheri Regina Dalmau Maria Carmen De Pablo Zarzosa Christian Delles Maria Manuela Fiuza Rahima Gabulova Bjørn Olav Haugen Christian Heiß Borja Ibáñez Stefan James Vikas Kapil Meral Kayıkçıoğlu Lars Køber Konstantinos C. Koskinas Emanuela H. Locati Sharon Macdonald Anastasia S. Mihailidou Borislava Mihaylova Richard Mindham Martin Bødtker Mortensen Sándor Nardai Lis Neubeck Jens Cosedis Nielsen Peter M Nilsson Agnès Pasquet Mónica Mendes Pedro Eva Prescott Amina Rakisheva Ernst Rietzschel Bianca Rocca Xavier Rosselló Jean‐Paul Schmid Eduard Shantsila Isabella Sudano Ana Teresa Timóteo Georgios Tsivgoulis Andrea Ungar Ilonca Vaartjes Frank L.J. Visseren Heinz Voeller Christiaan Vrints Adam Witkowski Maria‐Christina Zennaro Katja Zeppenfeld Naltin Shuka Nadia Laredj Noémi Pávó Ulvi Mirzoyev Philippe van de Borne Dragan Lović Arman Postadzhiyan Jure Samardžić Petros Agathangelou J Widimský Michael Hecht Olsen Wael El-Kilany Priit Pauklin Jari A. Laukkanen Romain Boulestreau Bezhan Tsinamdzgvrishvili Ulrich Kintscher Maria Marketou Dénes Páll Þórdís Jóna Hrafnkelsdóttir Eamon Dolan Talya Wolak Grzegorz Bilo

10.1093/eurheartj/ehae178 article EN other-oa European Heart Journal 2024-08-30

<h3>Objectives</h3> The interleukin-6 receptor (IL-6R) blocker tocilizumab (TCZ) reduces inflammatory disease activity in rheumatoid arthritis (RA) but elevates lipid concentrations some patients. We aimed to characterise the impact of IL-6R inhibition on established and novel risk factors active RA. <h3>Methods</h3> Randomised, multicentre, two-part, phase III trial (24-week double-blind, 80-week open-label), MEASURE, evaluated lipoprotein levels, high-density (HDL) particle composition,...

10.1136/annrheumdis-2013-204345 article EN cc-by-nc Annals of the Rheumatic Diseases 2013-12-24

In the diagnosis of obstructive coronary artery disease (CAD), computed tomography (CT) is an accurate, noninvasive alternative to invasive angiography (ICA). However, comparative effectiveness CT and ICA in management CAD reduce frequency major adverse cardiovascular events uncertain.We conducted a pragmatic, randomized trial comparing with as initial diagnostic imaging strategies for guiding treatment patients stable chest pain who had intermediate pretest probability were referred at one...

10.1056/nejmoa2200963 article EN New England Journal of Medicine 2022-03-04

Progressive CKD is generally detected at a late stage by sustained decline in eGFR and/or the presence of significant albuminuria. With aim early and improved risk stratification patients with CKD, we studied urinary peptides large cross-sectional multicenter cohort 1990 individuals, including 522 follow-up data, using proteome analysis. We validated that previously established multipeptide biomarker classifier performed significantly better detecting predicting progression than current...

10.1681/asn.2014050423 article EN Journal of the American Society of Nephrology 2015-01-15
Nete Tofte Morten Lindhardt Katarina Adamova Stephan J. L. Bakker Joachim Beige and 95 more Joline W. J. Beulens Andreas L. Birkenfeld Gemma Currie Christian Delles Ingo Dimos Lidmila Francová Marie Frimodt‐Møller Peter Girman Rüdiger Göke Tereza Havrdova Hiddo J.L. Heerspink Adriaan Kooy Gozewijn D. Laverman Harald Mischak Gerjan Navis Giel Nijpels Marina Noutsou Alberto Ortíz Aneliya Parvanova Frederik Persson John R. Petrie Piero Ruggenenti Femke Rutters Ivan Rychlík Justyna Siwy Goce Spasovski Marijn M. Speeckaert Matias Trillini Petra Zürbig Heiko von der Leyen Peter Rossing Silke Zimmermann Brit Rädisch Anika Hävemeier Annette Busmann Ulrike Wittkop Barbara Neuhaus Regina Ax-Smolarski Veit Zieglschmid Eva Bollweber Heidrun Wölk Viktor Rotbain Curovic Ninna Hahn Tougaard Mie K. Eickhoff Sascha Pilemann-Lyberg Signe Abitz Winther Signe Rosenlund Tine W. Hansen Bernt Johan von Scholten Christian Stevns Hansen Emilie H. Zobel Jens Christian Laursen Simone Theilade Lone Jelstrup Tina R. Juhl Dorthe Riis Jessie A. Hermann Anne G. Lundgaard Maja L.D. Halkjær Lene Aabo Therese Frost Lerche Maria Lajer Rikke J. Stefansen Maria Campbell Annika Durban Julia Raad Michael J. Prigge Marco Schiemann Robbie Wilson Sharon Kean Elizabeth Douglas Pamela Surtees Christina M. Gant Stanley M.H. Yeung Ilse J. M. Hagedoorn Joanne Flynn Joe Galloway Katriona Brooksbank Carolina Aparicio Ilian Iliev Francesco Nones Francesca Lo Bue Daniela Melacini Daniela Cugini Silvia Prandini V. Lecchi Svitlana Yakymchuk Giulia Gherardi Alessandro Villa Davide Villa Flavio Gaspari Antonio Cannatà Silvia Ferrari Nadia Stucchi Šárka Albrechtová

10.1016/s2213-8587(20)30026-7 article EN The Lancet Diabetes & Endocrinology 2020-03-02

Importance Pregnancy hypertension results in adverse cardiac remodeling and higher incidence of cardiovascular diseases later life. Objective To evaluate whether an intervention designed to achieve better blood pressure control the postnatal period is associated with lower than usual outpatient care during first 9 months postpartum. Design, Setting, Participants Randomized, open-label, blinded, end point trial set a single hospital UK. Eligible participants were aged 18 years or older,...

10.1001/jama.2023.21523 article EN JAMA 2023-11-11

Abstract Background and Aims Visit-to-visit systolic blood pressure variability (BPV) is an important predictor of cardiovascular (CV) outcomes. The long-term effect a period (BP) control, but with differential BPV, uncertain. Morbidity mortality follow-up UK participants in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure-Lowering Arm has been extended for up to 21 years determine CV impact mean (SBP) control BPV during trial, amongst those allocated amlodipine- atenolol-based...

10.1093/eurheartj/ehad814 article EN cc-by European Heart Journal 2024-01-31

A limitation of proteomic methods with respect to their clinical applicability is the lack possibilities directly deduce amount a protein or peptide from particular mass spectrometry (MS) spectrum. For quantification chronic kidney disease (CKD)-specific urinary polypeptides in capillary electrophoresis coupled (CE-MS), we compared signal intensity calibration based on either creatinine stable isotope labeled synthetic marker analogues (absolute quantification) those ion counting using...

10.1021/pr800401m article EN Journal of Proteome Research 2008-11-14

Urinary proteomics is emerging as a powerful non-invasive tool for diagnosis and monitoring of variety human diseases. We tested whether signatures urinary polypeptides can contribute to the existing biomarkers coronary artery disease (CAD). examined total 359 urine samples from 88 patients with severe CAD 282 controls. Spot was analyzed using capillary electrophoresis on-line coupled ESI-TOF-MS enabling characterization more than 1000 per sample. In first step "training set" biomarker...

10.1074/mcp.m700394-mcp200 article EN cc-by Molecular & Cellular Proteomics 2007-10-19
Coming Soon ...